2 months ago
CVS
AnalystsSteve SilverSteve Silver's Stock Forecasts
AnalystsSteve Silver
Analyst Ranking
Top 41%
#2252 out of 5550 analysts
Average Return
+6.62%
Win Rate
56%5 out of 9
Risk vs Reward
Poor
Good
Steve Silver's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Silk Road Medical IncSILK | +72.03% | $15.98 | $27.49 | 2024-03-07 - 2024-09-16 | Strong Buy |
Dexcom IncDXCM | +49.62% | $55.00 | $82.29 | 2025-11-07 - 2026-10-30 | Strong Buy |
Cvs Health CorpCVS | +21.91% | $74.03 | $90.25 | 2026-01-28 - 2026-10-30 | Strong Buy |
Dexcom IncDXCM | +11.91% | $80.62 | $90.22 | 2025-08-21 - 2026-08-20 | Strong Buy |
Space Exploration Technologies CorpSPCX | +1.21% | $133.11 | $134.72 | 2026-08-07 - 2026-10-30 | Strong Buy |
Steve Silver Analyst Color
Get additional color on Steve Silver's coverage of popular stocks
3 months ago
SPCX
Steve Silver's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Formfactor IncFORM | 2 | Hold | $140.00 | +59.95% | Maintains | 10 days ago |
Cvs Health CorpCVS | 2 | Strong Buy | $114.00 | +26.32% | Maintains | 2 months ago |
Space Exploration Technologies CorpSPCX | 1 | Strong Buy | $160.00 | +18.76% | Upgrades | 3 months ago |
Dexcom IncDXCM | 3 | Strong Buy | $96.00 | +16.66% | Maintains | 3 months ago |
Silk Road Medical IncSILK | 3 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Zerostack CorpZSTK | 1 | Strong Buy | $2,340.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.